IP Library Granted Patent US 9,839,466
Granted Patent B2
US 9,839,466 · App. 15/144,496 · Granted Dec 12, 2017

Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation

Inventors: David S. Utley (Redwood City, CA); John de Csepel (New York, NY)
Assignee: Covidien LP
A61B18/0218A61B18/1492A61B2018/0016A61B2018/0022A61B2018/00214A61B2018/00482A61B2018/00654A61B2018/00702A61B2018/00791A61B2018/00875A61B2018/00898A61B2018/0262A61B2018/124A61B2018/1497
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,466
App. No.
15/144,496
Granted
Dec 12, 2017
Kind
B2
Abstract

Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.

Claims (19)

1. A method of treating a gastrointestinal tract feature formed by a bariatric surgical procedure that has become dilated, comprising:

identifying a target area of the feature;

positioning a therapy device in the gastrointestinal tract adjacent to the target area; and

performing a non-surgical reduction therapy on the target area with energy delivered from the therapy device.

2. The method of claim 1 , further comprising:

controlling a depth of ablation into one or more layers of tissue in the target area.

3. The method of claim 2 , wherein controlling the depth of ablation comprises delivering sufficient energy to ablate the epithelial layer, the lamina propria, the muscularis mucosae, the submucosa, and the muscularis propria but insufficient energy to ablate the serosal layer.

4. The method of claim 1 , wherein performing the non-surgical reduction therapy comprises scarring the muscularis propria with the energy delivered from the therapy device.

5. The method of claim 1 , wherein performing the non-surgical reduction therapy comprises stricturing a lumen or stoma in the target area with the energy delivered from the therapy device.

6. The method of claim 1 , wherein performing the non-surgical reduction therapy comprises diminishing a compliance of tissue in the target area with the energy delivered from the therapy device.

7. The method of claim 1 , wherein performing the non-surgical reduction therapy comprises dampening peristaltic motility in the target area with the energy delivered from the therapy device.

8. The method of claim 7 , wherein dampening peristaltic motility comprises damaging nerve cells within the muscularis propria that affect motility.

9. The method of claim 1 , further comprising:

controlling delivery of energy across a tissue surface in the target area.

10. The method of claim 1 , wherein the energy is radiofrequency energy.

11. The method of claim 1 , wherein the energy is ultrasonic energy.

12. The method of claim 1 , wherein the energy is cryothermal energy.

13. The method of claim 1 , wherein the energy is microwave energy.

14. The method of claim 1 , wherein the energy is thermal energy transmitted from a heated fluid medium.

Assignments (5)
CHANGE OF NAME Recorded Feb 20, 2017
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 041757/0640 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2017
From: UTLEY, DAVID S.; DE CSEPEL, JOHN
To: BARRX MEDICAL, INC.
Reel/Frame 040956/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 12, 2017
From: BARRX MEDICAL LLC
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 040956/0417 →
CHANGE OF NAME Recorded Jan 12, 2017
From: BARRX MEDICAL, INC.
To: BARRX MEDICAL LLC
Reel/Frame 041349/0608 →
CHANGE OF NAME Recorded Jan 12, 2017
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 041349/0995 →
Continuity (4)
Continuation 13558506 · Jul 26, 2012
Division 12167902 · Jul 3, 2008
Provisional Application 60958543 · Jul 6, 2007
Related Publication 20170020592A1 · Jan 26, 2017